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In this issue of Chemistry & Biology, Laketa et al. describe the synthesis of a membrane permeant phosphoi-
nositide lipid that acts to stimulate PI(3,4,5)P3-dependent signaling without the need of growth factor
stimulation.The translation of extracellular signals to
a cellular response relies on temporal
and spatial cues provided by a complex
network of protein recruitment and modi-
fication on membrane subdomains. A crit-
ical cue of both the location of a given
membrane in the cell and its state of
activity is the phosphorylation state of
a subgroup of acidic phospholipids, the
phosphoinositide lipids.
Naturally occurring phosphoinositides
(PIs) can be phosphorylated on any
combination of the 30, 40, and 50 positions
of their inositol head group, giving rise to
seven possible lipid species with unique
distributions on cellular membranes
(Figure 1). In these membranes, PI spe-
cies often serve as part of a recruitment
mechanism for many cytosolic proteins,
thus targeting both a time and a place
where signaling cascades can be as-
sembled. Likewise, PIs are themselves
precursors of the second
messengers, inositol triphos-
phate (IP3) and diacylgly-
cerol.
The fact that different PI
species are confined to sepa-
rate membrane domains sug-
gests a high degree of re-
gulation by PI kinases and
phosphatases, in fact, a
highly coordinated series of
lipid phosphorylation and de-
phosphorylation events are
required for normal cellular
signaling and protein traf-
ficking. Misregulation of PI
metabolism contributes to
several human congenital
diseases (Attree et al., 1992;
Bielas et al., 2009; Bolino
et al., 2000; Jacoby et al.,
2009; Laporte et al., 1996).
More acutely, during the life-
time of individuals, phospho-
inositide dysregulation contributes to
several forms of cancers. Particularly
prominent among oncogenic mutations
are mutations in the cycle of enzymes
modulating the production of PI(3,4,5)P3
in response to growth factor cues (Denley
et al., 2009; Li et al., 1997), all mutations
that lead to the increase of the highly
charged PI, PI(3,4,5)P3 (or PIP3).
Recent studies show that more than
two hundred individual proteins specifi-
cally associate with PIP3-containing
complexes alone (Catimel et al., 2009).
Given the plethora of possible signaling
interactions found and their pleiotropic
effects on cell morphology and survival,
unraveling the effects of individual phos-
phoinositide species in different cellular
contexts is of critical interest to the field
of cell biology. However, given that
many PI binding domains show high
affinity for their substrate coupled with
low specificity, it can prove difficult in
many cases to unravel the influence of
individual PIs on protein targeting and
function in vivo.
How then to sort out all these effects?
Genetic approaches have been fruitful in
assigning roles of individual PI metabo-
lizing enzymes to cell biological pro-
cesses, but the lipid product itself is often
compensated for by other enzymes.
Pharmacology has also been used to
tackle these themes, such as the use
of wortmannin and LY294002 to inhibit
PI-30 kinases, but for many enzymes there
is no compound available for specific
pharmacological manipulations.
Recent advances have been made in
making acute, targeted changes in local
PI concentration using a bipartite system
of PI phosphatases (Fili et al., 2006; Varnai
et al., 2006) or kinases (Suh et al., 2006)
that heterodimerize to a targeting
construct upon the addition
of the small molecule rapa-
mycin. These approaches
have been extremely power-
ful for resolving the contribu-
tion of individual phospho-
inositide lipids to many
cellular processes, but they
rely on easily transfectable
cells, requiring as they do the
incorporation of three plas-
mids: the two halves of the
dimerizable construct and a
reporter plasmid.
Laketa et al. (2009) add
another string to the bows of
biologists looking at the
signaling effects mediated
by PI metabolism by directly
adding a novel PI analog,
PI(3,4,5,6)P4, to cells. To facil-
itate the transfer of these
lipids to the inner leaflet of
the plasma membrane, they
Figure 1. The Distribution of Different PIP Species in Cellular
Membranes
The most abundant PIP species, PI(4,5)P2 and PI4P, are predominantly found
in the plasma membrane and Golgi, respectively. PI(3,4,5)P3 is transiently
produced at the plasma membrane by PI 30-kinases acting on PI(4,5)P2 in
response to growth factor receptor activation. Image kindly provided by
Dr. Andrea Raimondi (De Camilli Lab).Chemistry & Biology 16, November 25, 2009 ª2009 Elsevier Ltd All rights reserved 1127
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Previewshave shielded the charged groups of the
inositol head group with butyrate and AM
esters, which are subsequently hydro-
lyzed in the cell cytosol. Intriguingly, it
would appear that, despite the inclusion
of a novel phosphate on the 6’ position,
many PIP3 binding and metabolizing
proteins are capable of being recruited
by the PIP4 molecule. Laketa et al. (2009)
show that PIP4/AM is a more potent
stimulator of several PIP3-dependent
processes in the cell than is the related
derivative PIP3/AM, suggesting that the
novel PIP4 is not as accessible to degra-
dative enzymes (such as endogenous 30
or 50 phosphatases) as is PIP3 once cyto-
solic hydrolases have removed the AM
and butyrate groups from the inositol
ring. Using this technique, they are able
to bypass the requirement for growth
factor stimulation and subsequent PI
30-kinase activation, to look directly at
a subset of PI dependent signaling in the
cell, including their feedback onto growth
factor receptors themselves. An exciting
possibility is that the inclusion of the 6’
phosphate group in PIP4 will render thisA Versatile Actor F
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RNA stars in many roles within the
mechanism of action for natural ribo
in a pathogenic bacterium.
Whether it’s on the big screen or on the
small one, in the lead role or in support,
some actors seem to be able to play any
type of role. Two of the most versatile
actors of today, Christopher Walken and
Meryl Streep, appeared together in the
1978 film ‘‘The Deer Hunter,’’ for which
Walken was awarded an Oscar for Best
Supporting Actor, while Streep was nomi-
nated for Best Supporting Actress. Since
then, both actors have gone on to appear
in countless memorable roles, and I’m
1128 Chemistry & Biology 16, November 25analog inaccessible to some PIP3 binding
proteins, thus becoming a growth factor-
independent agonist of pathways such
as the PDK1, AKT/PKB pathway, which
is characterized in great detail in this
article.
Use of this new molecule, in combina-
tion with other methods of manipulating
PI metabolism, has the potential to
untangle some of the complex web of
protein modification and signaling feed-
back that growth factor signaling evokes
in models of health and disease.
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an increasing variety of roles in biological
systems. Far from being a bit player medi-
ating translation, RNA appears in diverse
starring roles in both eubacteria (Waters
and Storz, 2009) and eukaryotes (Rana,
2007).
The bacterial kingdom also has its share
of versatile players, including the path-
ogen Listeria monocytogenes, which
excels at playing the bad guy. In addition
to being a leading cause of food-borne
illness in humans, L. monocytogenes can
